ArticleScientific reports2025
A design for an efficient functional panel that determines platelet exhaustion levels to differentiate responder and non-responder ITP patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune thrombocytopenia (ITP) is marked by decreased platelet counts and an increased bleeding risk, while functional platelet exhaustion may also underlie its clinical variability. This study investigates whether platelet functional competence can help differentiate "responder" (R) from "non-responder" (NR) ITP patients. Platelets obtained from 28 chronic ITP patients and 20 healthy controls, either in resting condition or in the presence of PMA, were subjected to flow cytometry, where the levels of platelet activation markers (P-selectin expression, PAC-1 binding) and reactive oxygen species (ROS) were assessed. In ITP, baseline levels of P-selectin and PAC-1 were higher compared to healthy controls, while their levels in response to PMA were significantly lower (p˂0.05). Baseline ROS also showed a significant difference between ITP and controls, and ROS generation in response to PMA was reduced in ITP compared to controls (p˂0.05). "NR" exhibited elevated basal P-selectin and diminished PMA-induced activation while bleeding scores showed no correlation with basal P-selectin. ROC curve analysis and multiple logistic regression models identified PMA-induced ROS and P-selectin responses as strong predictors of bleeding severity and treatment response in ITP. Panel analysis, including platelet activation markers and ROS generation in response to PMA, successfully distinguished the disease status with an adjusted AUC of 92 (95%CI:80.7-100), an optimum cut-off value of 0.228, sensitivity of 87.5%, and specificity of 85.0%. A novel composite index of platelet functional analysis was developed to overcome limitations of conventional assessment of ITP status. This multifactor panel accurately reflects platelet functional state while helping to distinguish between responder and non-responder patients. The panel could offer a promising tool for improved diagnosis, prognosis, and individualized patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.